Emerging therapeutic options for non-alcoholic fatty liver disease: A systematic review

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has become a prevalent cause of chronic liver disease and ranks third among the causes of transplantation. In the United States alone, annual medical costs are approximately 100 billion dollars. Unfortunately, there is no Federal Drug Administrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tidwell, Jasmine, Balassiano, Natalie, Shaikh, Anjiya, Nassar, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Systematic Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494562/
https://www.ncbi.nlm.nih.gov/pubmed/37701920
http://dx.doi.org/10.4254/wjh.v15.i8.1001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494562/
https://www.ncbi.nlm.nih.gov/pubmed/37701920
http://dx.doi.org/10.4254/wjh.v15.i8.1001

Ejemplares similares